← Back to headlines
Gilead Sciences Details Strategic Deals and Future Pipeline Updates
Gilead Sciences has provided details on its deals with Tubulis, Ouro, and Arcellx, which are seen as pipeline catalysts, with further updates expected by 2026.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
